Biotalys NV Discloses Share Capital and Voting Rights Update
News related to:Biotalys NV · 2 min read
Ghent, BELGIUM, Oct. 13, 2026 /CourierPR/ -- Biotalys NV, an Agricultural Technology (AgTech) company based in Ghent, Belgium, has announced changes to its capital structure and shareholding details in accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings. The company’s share capital stands at EUR 6,720,420.45, with a total of 45,448,940 securities carrying voting rights, all of which are ordinary shares.
The company has also disclosed the existence of unissued ESOP Warrants, which entitle their holders to subscribe for a total of 1,779,400 profit certificates. If and when these certificates are issued, they will automatically convert into a maximum of 889,700 securities carrying voting rights, all of which will be ordinary shares. Additionally, Biotalys has 1,248,660 ESOP Warrants outstanding, each entitling their holders to subscribe for a total of 1,248,660 securities carrying voting rights.
In a related development, the company has reported an increase in its share capital through the issue of 4,484 shares at an issue price of one EUR per share. These shares were issued following the conversion of share-units awarded to independent directors in accordance with the company’s remuneration policy. Each share unit contains the obligation to subscribe to one new share of the company at an issue price of one EUR per share-unit. Cash settlement is possible, and the conditions of the share units are described in the remuneration policy of the company.
According to the Belgian Act, a notification to the company and the Belgian Financial Services and Markets Authority (FSMA) is required by all natural and legal persons in each case where the percentage of voting rights attached to the securities held by such persons in the company reaches, exceeds, or falls below the threshold of 5%, 10%, and every subsequent multiple of 5% of the total number of voting rights in the company.
Biotalys, founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), continues to develop precision biocontrol solutions for crop protection. The company’s AGROBODY® technology platform is aimed at addressing key crop pests and diseases across the entire value chain, from soil to plate.